The role of hydrolysis in the detoxification of 1,2:3,4-diepoxybutane by human, rat, and mouse liver and lung in vitro

被引:68
作者
Boogaard, PJ
Bond, JA
机构
[1] CHEM IND INST TOXICOL, RES TRIANGLE PK, NC 27709 USA
[2] SHELL INT CHEM BV, SHELL RES & TECHNOL CTR, DEPT MOL TOXICOL, NL-1030 BN AMSTERDAM, NETHERLANDS
关键词
D O I
10.1006/taap.1996.0328
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1,2:3,4-Diepoxybutane (BDE) is probably the ultimate genotoxic metabolite of the rodent carcinogen 1,3-butadiene (BD). The formation of BDE from BD has been characterized in vitro using tissues from rats, mice, and humans. For assessment of human risk following exposure to BD, a quantitative understanding between the balance of formation and inactivation of BDE is essential. BDE can be removed by glutathione (GSH) conjugation and by hydrolysis. Recently, significant species differences were reported in GSH conjugation of BDE in vitro, with rats being more efficient than humans and mice being much more efficient than either rats or humans (Boogaard et al., Toxicol. Appl. Pharmacol. 136, 307, 1996). In the present study the microsomal hydrolysis of BDE was quantified using tissues of rats, mice, and humans. Hydrolysis of BDE was well described by Michaelis-Menten kinetics. Two metabolites, erythritol and anhydroerythritol, were identified following incubation of BDE with human microsomes, but these metabolites did not fully account for the disappearance of BDE, suggesting that there may be other as yet unidentified routes of metabolism. In contrast to GSH conjugation, which was most efficient in mice compared with rats or humans, the efficiency of hydrolysis as expressed by V-max/K-m was much lower in mouse (3.93 mu l/min/mg protein) than in rat (19.2) or human (32.5) Liver. Pulmonary hydrolysis was also most efficient in humans, with average V-max/K-m values of 7.7, 6.7, and 2.7 mu l/min/mg protein for humans, mice, and rats, respectively. However, the interindividual variation among the human samples was considerable with individual V-max/K-m values varying from 17.9 to 49.5 mu l/min/mg protein for liver and from 4.57 to 16.2 mu l/min/mg protein for lung tissue. This means that the heterogeneity among humans in the formation as well as in the removal of BDE will be an important factor in human risk assessment. The present data, coupled with earlier studies on formation and removal of BDE and the observation that GSH conjugation of BDE is a potentially mutagenic pathway, explain the high susceptibility of mice to BD-induced carcinogenesis. (C) 1996 Academic Press, Inc.
引用
收藏
页码:617 / 627
页数:11
相关论文
共 32 条
[1]   EPIDEMIOLOGIC AND MECHANISTIC DATA SUGGEST THAT 1,3-BUTADIENE WILL NOT BE CARCINOGENIC TO HUMANS AT EXPOSURES LIKELY TO BE ENCOUNTERED IN THE ENVIRONMENT OR WORKPLACE [J].
BOND, JA ;
RECIO, L ;
ANDJELKOVICH, D .
CARCINOGENESIS, 1995, 16 (02) :165-171
[2]   Glutathione conjugation of 1,2:3,4-diepoxybutane in human liver and rat and mouse liver and lung in vitro [J].
Boogaard, PJ ;
Sumner, SCJ ;
Bond, JA .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1996, 136 (02) :307-316
[3]  
CARPENTER C. P., 1944, Journal of Industrial Hygiene and Toxicology, V26, P69
[4]  
*CHEM ENG ENWS, 1995, CHEM ENG NEWS, V10, P16
[5]  
*CHEM ENG ENWS, 1994, CHEM ENG NEWS, V29, P11
[6]   MUTAGENICITY OF BUTADIENE AND ITS EPOXIDE METABOLITES .2. MUTATIONAL SPECTRA OF BUTADIENE, 1,2-EPOXYBUTENE AND DIEPOXYBUTANE AT THE HPRT LOCUS IN SPLENIC T-CELLS FROM EXPOSED B6C3F1 MICE [J].
COCHRANE, JE ;
SKOPEK, TR .
CARCINOGENESIS, 1994, 15 (04) :719-723
[7]   MUTAGENICITY OF BUTADIENE AND ITS EPOXIDE METABOLITES .1. MUTAGENIC POTENTIAL OF 1,2-EPOXYBUTENE, 1,2,3,4-DIEPOXYBUTANE AND 3,4-EPOXY-1,2-BUTANEDIOL IN CULTURED HUMAN LYMPHOBLASTS [J].
COCHRANE, JE ;
SKOPEK, TR .
CARCINOGENESIS, 1994, 15 (04) :713-717
[8]  
CSANADY GA, 1993, CARCINOGENESIS, V14, P784
[9]   COMPARISON OF THE BIOTRANSFORMATION OF 1,3-BUTADIENE AND ITS METABOLITE, BUTADIENE MONOEPOXIDE, BY HEPATIC AND PULMONARY TISSUES FROM HUMANS, RATS AND MICE [J].
CSANADY, GA ;
GUENGERICH, FP ;
BOND, JA .
CARCINOGENESIS, 1992, 13 (07) :1143-1153
[10]   TOXICOKINETICS OF INHALED 1,3-BUTADIENE IN MONKEYS - COMPARISON TO TOXICOKINETICS IN RATS AND MICE [J].
DAHL, AR ;
SUN, JD ;
BIRNBAUM, LS ;
BOND, JA ;
GRIFFITH, WC ;
MAUDERLY, JL ;
MUGGENBURG, BA ;
SABOURIN, PJ ;
HENDERSON, RF .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1991, 110 (01) :9-19